Fundz

VenoStent completes $20M Series A funding with $4M investment from Norwest Venture Partners to fund U.S. clinical trial and NIH SBIR grant

PRIVATEJun 27, 2024

Amount Raised

$20 Million

Round Type

Series A

HoustonHealthcare

Investors

IAG Capital PartnersGood Growth CapitalNorwest Venture Partners

Description

VenoStent, Inc. closed an additional $4 million from Norwest Venture Partners to complete its Series A round at $20 million. The funding will be used to fund its U.S. clinical trial for a breakthrough medical device and to support its NIH SBIR Phase II Grant.

Quick answer

VenoStent raised $20 Million in a Series A round, dated June 27, 2024. Investors: IAG Capital Partners, Good Growth Capital and Norwest Venture Partners. VenoStent is based in Houston, Texas, United States.

How much did VenoStent raise?
VenoStent raised $20 Million in a Series A round on June 27, 2024.
Who invested in VenoStent?
IAG Capital Partners, Good Growth Capital and Norwest Venture Partners are named as investors in this round.
What does VenoStent do?
VenoStent is a venture backed, clinical stage medical device and tissue engineering company that’s developed bioabsorbable polymer scaffolds in order to vastly improve vascular surgery outcomes.
Where is VenoStent based and how big is it?
VenoStent is based in Houston, Texas, United States. Fundz records about 36 employees.
Who are the decision-makers at VenoStent?
Fundz holds 1 contact at VenoStent. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as VenoStent that raised within 45 days of this round, from Fundz verified event records.

  • Hummingbird Healthcare raised $9.9M on May 29, 2024.
  • Hummingbird Healthcare raised $1.1M on May 29, 2024.
  • Eva Medtec raised $50K on August 10, 2024.
  • InterShunt Technologies raised $18M on August 9, 2024.
  • Tenax Therapeutics raised $100M on August 8, 2024.
  • Indaptus Therapeutics, Inc. raised $205K (Pre-Seed) on August 7, 2024.

Who to call at VenoStent, and when

A new round usually means VenoStent is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day VenoStent raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VenoStent, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VenoStent. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VenoStent

Location

2450 HOLCOMBE BLVD.

Houston, Texas, United States

About

VenoStent is a venture backed, clinical stage medical device and tissue engineering company that’s developed bioabsorbable polymer scaffolds in order to vastly improve vascular surgery outcomes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VenoStent raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts9 people are listed at VenoStent. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for VenoStent's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

VenoStent raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.